Unknown PHASE4 INTERVENTIONAL 2-arm NCT05065073

Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography (GE OCT)

Sponsor: Minneapolis Heart Institute Foundation

Conditions Contrast Media Reaction Coronary Artery Disease

Updated 5 times since 2021 Last updated: Oct 19, 2021 Started: Sep 30, 2021 Primary completion: Mar 31, 2023 Completion: Jun 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05065073, this PHASE4 trial focuses on Contrast Media Reaction and Coronary Artery Disease and remains ongoing. Sponsored by Minneapolis Heart Institute Foundation, it has been updated 5 times since 2021, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Nov 2023 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Nov 2021 — Nov 2023 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Oct 2021 — Nov 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Minneapolis Heart Institute Foundation

Data source: Minneapolis Heart Institute Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States